Related Experiment Videos
Factors associated with delay to treatment for acute myocardial infarction in Ireland
H M McGee1, D O'Callaghan, G A MacGowan
1Department of Cardiology, Beaumont Hospital, Dublin.
Irish data from the ISIS-2 multi-centre study of thrombolytic therapy has indicated longer delays to treatment for acute myocardial infarction (AMI) than in other countries (7.9 vs 6.9 hours, p < 0.001). Further examination of this database (n = 831 patients) found no influence of age and sex of patient on delay times. Distance from hospital was not associated with delay while previous experience of MI was marginally associated with decreased delay (previous MI: 7.1 vs no previous MI: 8 hours, p = 0.06). These relatively lengthy Irish delays require further investigation to inform management strategies aimed at reducing delay.
Irish data from the ISIS-2 multi-centre study of thrombolytic therapy has indicated longer delays to treatment for acute myocardial infarction (AMI) than in other countries (7.9 vs 6.9 hours, p < 0.001). Further examination of this database (n = 831 patients) found no influence of age and sex of patient on delay times. Distance from hospital was not associated with delay while previous experience of MI was marginally associated with decreased delay (previous MI: 7.1 vs no previous MI: 8 hours, p = 0.06). These relatively lengthy Irish delays require further investigation to inform management strategies aimed at reducing delay.